MAP2K7 and melanoma: Similarly, in NRAS-mutant melanoma cells treated with combination MEK and CDK4/6 inhibitors, scRNA-seq revealed distinct cell clusters reflecting heterogeneity in transcriptional response to treatment, and differences in response was postulated to cause outgrowth of intrinsically resistant melanoma subpopulations.53